<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02381912</url>
  </required_header>
  <id_info>
    <org_study_id>SSBC-2015</org_study_id>
    <nct_id>NCT02381912</nct_id>
  </id_info>
  <brief_title>Sexual Function in Patients Suspected of Non-muscle Invasive Bladder Cancer</brief_title>
  <official_title>Sexual Function in Patients Suspected of Non-muscle Invasive Bladder Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Herlev Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Herlev Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to investigate sexual function in patients suspected of non
      muscle invasive bladder cancer (NMIBC). The investigators hypothesis is that reduced sexual
      function is underdiagnosed in patients with non-muscle invasive bladder cancer and that
      active examination and treatment may worsen the sexual function.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2015</start_date>
  <completion_date type="Actual">January 2016</completion_date>
  <primary_completion_date type="Actual">January 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in sexual function</measure>
    <time_frame>4 months</time_frame>
    <description>Change in sexual function measured by the &quot;EORTC QLQ-BLS24 sexual functioning questions&quot;</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in erectile function</measure>
    <time_frame>4 months</time_frame>
    <description>Change in erectile function measured by the Erection Hardness Scale</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">210</enrollment>
  <condition>Urinary Bladder Neoplasms</condition>
  <condition>Sexual Dysfunction, Physiological</condition>
  <condition>Sexual Dysfunctions, Psychological</condition>
  <condition>Erectile Dysfunction</condition>
  <condition>Hematuria</condition>
  <arm_group>
    <arm_group_label>Hematuria - NMIBC</arm_group_label>
    <description>Primary hematuria due to NMIBC.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hematuria - other cause</arm_group_label>
    <description>Other non-malignant cause of hematuria.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>EORTC QLQ-C30 and EORTC BLS-24 questionnaire</intervention_name>
    <description>Questionnaires answered at baseline and 4 months follow up.</description>
    <arm_group_label>Hematuria - NMIBC</arm_group_label>
    <arm_group_label>Hematuria - other cause</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with primary hematuria.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with primary hematuria, both gross and microscopic

          -  Men and women older or equal to 40 years of age

          -  Signed informed consent statement

        Exclusion Criteria:

          -  Men and women younger than 40 years of age

          -  Patients with recurrent hematuria and known causative disease

          -  Already known urogenital cancer

          -  Previous massive pelvic surgery or pelvic radiotherapy

          -  TUR-P within the last 2 months

          -  Participants diagnosed with tumors originating from the ureters, renal pelvis and
             kidney, and bladder tumors at T stage more than or equal to T1b.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter B Østergren, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Herlev Hospital, Department of Urology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Herlev Hospital</name>
      <address>
        <city>Herlev</city>
        <zip>2730</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <reference>
    <citation>Kowalkowski MA, Chandrashekar A, Amiel GE, Lerner SP, Wittmann DA, Latini DM, Goltz HH. Examining sexual dysfunction in non-muscle-invasive bladder cancer: results of cross-sectional mixed-methods research. Sex Med. 2014 Aug;2(3):141-51. doi: 10.1002/sm2.24.</citation>
    <PMID>25356311</PMID>
  </reference>
  <reference>
    <citation>van der Aa MN, Bekker MD, van der Kwast TH, Essink-Bot ML, Steyerberg EW, Zwarthoff EC, Sen FE, Elzevier HW. Sexual function of patients under surveillance for bladder cancer. BJU Int. 2009 Jul;104(1):35-40. doi: 10.1111/j.1464-410X.2008.08333.x. Epub 2009 Jan 14.</citation>
    <PMID>19154473</PMID>
  </reference>
  <reference>
    <citation>Goossens-Laan CA, Kil PJ, Ruud Bosch JL, De Vries J. Pre-diagnosis quality of life (QoL) in patients with hematuria: comparison of bladder cancer with other causes. Qual Life Res. 2013 Mar;22(2):309-15. doi: 10.1007/s11136-012-0163-1. Epub 2012 Mar 30.</citation>
    <PMID>22461137</PMID>
  </reference>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 5, 2015</study_first_submitted>
  <study_first_submitted_qc>March 5, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 6, 2015</study_first_posted>
  <last_update_submitted>March 8, 2016</last_update_submitted>
  <last_update_submitted_qc>March 8, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 9, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Herlev Hospital</investigator_affiliation>
    <investigator_full_name>Peter Busch Østergren</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Bladder Neoplasms</mesh_term>
    <mesh_term>Erectile Dysfunction</mesh_term>
    <mesh_term>Hematuria</mesh_term>
    <mesh_term>Sexual Dysfunctions, Psychological</mesh_term>
    <mesh_term>Sexual Dysfunction, Physiological</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

